Events
Melanoma in the Era of COVID-19
Date: Monday, April 20, 2020
Time: Noon - 1 p.m. PST
Place: Virtual /Remote Conference
Join us for a virtual roundtable discussion as we delve into the current state of COVID-19 as it pertains to melanoma patients and treatments.
How has this virus affected melanoma providers? What treatments are being prioritized or deprioritized? How has this affected clinical research? What can you do if you cannot be seen by your provider?
A panel of interdisciplinary melanoma experts from OHSU (see full list below) will take on these topics and more, including YOUR questions in a roundtable discussion.
Register and submit your questions for the virtual conference today!
Speakers/panelists
Sancy Leachman, M.D., Ph.D.
Professor and Chair, OHSU Dermatology
Director, Melanoma Program, Knight Cancer Institute
'General' in the War on Melanoma™
Anna Bar, M.D.
Associate Professor of Dermatology
Co-director, Mohs micrographic surgery
Elizabeth Berry, M.D.
Assistant Professor of Dermatology
Director, Multidisciplinary Pigmented Lesion Clinic
Dale Han, M.D.
Associate Professor of Surgery
Division of Surgical Oncology
Aimee Kohn, M.D., Ph.D.
Assistant Professor of Medicine
Division of Hematology/Medical Oncology
Rajan Kulkarni, M.D., Ph.D.
Associate Professor of Dermatology
Member, Center For Early Detection Research (CEDAR)
Catherine Morgans, Ph.D.
Associate Professor of Chemical Physiology and Biochemistry
Jone Sampson, M.D.
Geneticist
Professor of Molecular Genetics
Susan Tofte, F.N.P.
Assistant Professor of Dermatology
Alexander Witkowski, M.D., Ph.D.
Assistant Professor of Dermatology
Co-director, Skin Cancer Imaging Center
